Abstract
Hepatocellular carcinoma (HCC) is a major cause of cancer death, and chronic hepatitis B is a serious worldwide problem. The epidemiology of HCC is distinctive. Hepatitis B virus (HBV) plays a major role in hepatocarcinogenesis. Prevention of HBV-related HCC is a key issue in current hepatology. This paper describes the prevention and clinical features of HBV-related HCC, along with a short review of the disease.
MeSH terms
- Antiviral Agents / therapeutic use
- Carcinoma, Hepatocellular / etiology*
- Carcinoma, Hepatocellular / prevention & control
- Carcinoma, Hepatocellular / therapy
- Carcinoma, Hepatocellular / virology*
- Guidelines as Topic
- Hepatitis B virus* / genetics
- Hepatitis B virus* / pathogenicity
- Hepatitis B, Chronic / complications*
- Humans
- Liver Neoplasms / etiology*
- Liver Neoplasms / prevention & control
- Liver Neoplasms / therapy
- Liver Neoplasms / virology*
- Recurrence
- Viral Load